Megan Ingram

Subscribe to Megan Ingram's Posts
Megan Ingram focuses her practice on assessing and mitigating antitrust risk in public and private M&A transactions. She supports US and international clients with merger review, obtaining clearance under the Hart-Scott-Rodino Act, antitrust compliance, and governmental antitrust investigations. Megan has experience across multiple industries, including software and technology, healthcare and life sciences, consumer products, aerospace and defense, and industrials. Read Megan Ingram's full bio. 

Antitrust Under Trump: March 2025 Updates


By , and on Apr 1, 2025
Posted In DOJ Developments, FTC Developments

The Trump administration has taken significant steps to reshape antitrust enforcement by exerting greater control over the Federal Trade Commission (FTC), firing two Democratic FTC commissioners. Leadership has also begun to outline more of their priorities in speeches and interviews. These changes outline antitrust enforcement priorities, with a stronger emphasis on economic analysis and litigation...

Continue Reading



Antitrust Under Trump: Initial Policies and Actions


By , and on Mar 6, 2025
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Joint Ventures/Competitor Collaboration, Mergers & Acquisitions, Monopolization/Abuse of Dominance

The Trump administration has initiated significant changes in antitrust policy through key appointments and policy announcements. The administration announced that the Federal Trade Commission (FTC) and US Department of Justice (DOJ) will continue using the 2023 Merger Guidelines and expressed support for new Hart-Scott-Rodino (HSR) rules. Additionally, the FTC outlined its goals, which include improving...

Continue Reading



BLOG EDITORS

STAY CONNECTED

TOPICS

ARCHIVES

Ranked In Chambers USA 2022
US Leading Firm 2022